Traditional polychromatic flow cytometry is currently the gold standard for instruments used in the detection of hematological malignancies in the clinical laboratory.
Initial work on spectral cytometry was first presented in 2004. Since then the technique has grown steadily, mainly within the field of basic research.
However, the first CE-IVD certified spectral cytometer recently entered the market allowing its extension into a clinical diagnostics setting.
This talk will compare and contrast the two methods based on our experience at the HUG Clinical Flow Cytometry Laboratory in Geneva. These results will hopefully lead to a wider discussion of the direction for Clinical flow cytometry in the future